Works matching IS 14741776 AND DT 2005 AND VI 4 AND IP 2
1
- Nature Reviews Drug Discovery, 2005, v. 4, n. 2, p. 161, doi. 10.1038/nrd1635
- Article
2
- Nature Reviews Drug Discovery, 2005, v. 4, n. 2, p. 131, doi. 10.1038/nrd1630
- Swanson, Chad J.;
- Bures, Mark;
- Johnson, Michael P.;
- Linden, Anni-Maija;
- Monn, James A.;
- Schoepp, Darryle D.
- Article
3
- Nature Reviews Drug Discovery, 2005, v. 4, n. 2, p. 94, doi. 10.1038/nrd1650
- Article
4
- Nature Reviews Drug Discovery, 2005, v. 4, n. 2, p. 93, doi. 10.1038/nrd1648
- Article
5
- Nature Reviews Drug Discovery, 2005, v. 4, n. 2, p. 101, doi. 10.1038/nrd1637
- Noseworthy, John H.;
- Kirkpatrick, Peter
- Article
6
- Nature Reviews Drug Discovery, 2005, v. 4, n. 2, p. 1051, doi. 10.1038/nrd1639
- Article
7
- Nature Reviews Drug Discovery, 2005, v. 4, n. 2, p. 1061, doi. 10.1038/nrd1643
- Article
8
- Nature Reviews Drug Discovery, 2005, v. 4, n. 2, p. 107, doi. 10.1038/nrd1631
- Leurs, Rob;
- Bakker, Remko A.;
- Timmerman, Henk;
- de Esch, Iwan J. P.
- Article
9
- Nature Reviews Drug Discovery, 2005, v. 4, n. 2, p. 145, doi. 10.1038/nrd1632
- Article
10
- 2005
- Gregson, Nigel;
- Sparrowhawk, Keiron;
- Mauskopf, Josephine;
- Paul, John
- journal article
11
- Nature Reviews Drug Discovery, 2005, v. 4, n. 2, p. 165, doi. 10.1038/nrd1634
- Licinio, Julio;
- Wong, Ma-Li
- Article
13
- Nature Reviews Drug Discovery, 2005, v. 4, n. 2, p. 99, doi. 10.1038/nrd1636
- Fitzhenry, David;
- Sandberg, Leslie
- Article
14
- Nature Reviews Drug Discovery, 2005, v. 4, n. 2, p. 104, doi. 10.1038/nrd1642
- Article
15
- Nature Reviews Drug Discovery, 2005, v. 4, n. 2, p. 1061, doi. 10.1038/nrd1640
- Article
16
- Nature Reviews Drug Discovery, 2005, v. 4, n. 2, p. 173, doi. 10.1038/nrd1655
- Article